This research study is testing trevogrumab, garetosmab, and Wegovy® (semaglutide) either alone or in different combinations with each other. The goal of the research study is to see how safe and effective the study medication is when combined with Wegovy® (semaglutide) in overweight or obese patients. Some participants will receive the study medication + Wegovy® (semaglutide), while others will receive a placebo + Wegovy® (semaglutide).  (A placebo looks like the study medication but does not contain any active ingredients.) 

Screening and all study visits will be at our San Diego area research clinic. Transportation can be arranged by and paid for by ProSciento. You do not need to live in San Diego, CA to participate. We encourage those that reside in neighboring cities to also participate.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you.

Start the process today! During your 1-on-1 call, we’ll get more health information from you. We will use this information to find out if you are eligible for this study or any other paid and actively enrolling studies at our research center.

We are looking for adults to take part in a paid device study in San Diego. The Orange Biomed OBM rapid A1c At Home provides a quantitative measurement of the percent of glycated hemoglobin (%HbA1c, %A1C) levels in whole blood samples. The test is being developed under standard Design Controls in anticipation of FDA 510(k) clearance for over-the-counter use in monitoring long-term glycemic control for people with diabetes. The total study duration is 1 visit. 

Once participants undergo the sampling procedures for the finger sticks (additional finger sticks may be necessary due to an inadequate blood drop obtained but with no more than a total of three finger sticks performed) and one venous draw (two attempts are allowed for the study), their study participation is complete. 

There will be no cost to you for the study drug, visits, tests, or supplies that are required for the study.

The study is researching experimental drugs called trevogrumab and garetosmab in combination with another drug, semaglutide (Wegovy®). This study will be done in two parts, Part A and Part B where different study drugs will be tested. The aim of Part A of the study is to see how safe and tolerable the study drug is in healthy people.

Trevogrumab is a type of drug called a monoclonal antibody. Antibodies are proteins naturally found in your blood that fight infections. A monoclonal antibody is a special kind of antibody that is manufactured as a medication to target specific proteins in the body. Trevogrumab targets a protein named Myostatin, blocking its function. Myostatin is a protein that normally acts on muscle and causes muscle wasting. Trevogrumab is being developed for the treatment of obesity.

There will be no cost to you for the study drug, visits, tests, or supplies that are required for the study.

We’re looking for people to participate in a study being done to find out more about an investigational device (Biolinq MicroArray Intradermal Continuous Glucose Monitoring (CGM) system). The main purpose of this study is to find out if the Investigational CGM is safe and wearable and if changes to the system may help improve performance and the user’s experience. This study will compare the performance of the Investigational CGM with different blood glucose measurements, such as lab measurements, commercial blood glucose meters, and commercially available CGM devices that are used to monitor glucose levels in people with diabetes.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you. We also partner with Uber Health to provide complimentary transportation for our patients. 

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status.

We are happy to answer any questions you may have, and we will provide all details about the study during your phone call with our caring and highly trained healthcare team.

We’re looking for people to participate in a study being done to find out more about an investigational device (Biolinq MicroArray Intradermal Continuous Glucose Monitoring (CGM) system). The main purpose of this study is to find out if the Investigational CGM is safe and wearable and if changes to the system may help improve performance and the user’s experience. This study will compare the performance of the Investigational CGM with different blood glucose measurements, such as lab measurements, commercial blood glucose meters, and commercially available CGM devices that are used to monitor glucose levels in people with diabetes.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you. We also partner with Uber Health to provide complimentary transportation for our patients. 

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status.

We are happy to answer any questions you may have, and we will provide all details about the study during your phone call with our caring and highly trained healthcare team.

We’re looking for people to participate in a study that is researching a new medication. The study drug, HU6, may support advancing treatments for patients living with obesity and type 2 diabetes. 

You do not need health insurance to participate. All study tests and examinations will be at no cost to you. We also partner with Uber Health to provide complimentary transportation for our patients. 

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status.

We are happy to answer any questions you may have, and we will provide all details about the study during your phone call with our caring and highly trained healthcare team.

We’re looking for people to participate in a study that is researching a new medication. The study medication is in development for the potential treatment of hypoglycemia (low blood sugar) in patients with post bariatric hypoglycemia (PBH). For this part of the study we are looking for people without this condition.

You do not need health insurance to participate. All study tests and examinations will be at no cost to you. We also partner with Uber Health to provide complimentary transportation for our patients. 

To join this paid research study, you will need to complete an easy and risk-free, 20-minute phone questionnaire about you and your current health status.

We are happy to answer any questions you may have, and we will provide all details about the study during your phone call with our caring and highly trained healthcare team.